Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)
Anne Lohse, Timothée Klopfenstein, J.C. Balblanc, Pierre‐Yves Royer, Marie Bossert, Vincent Gendrin, Aline Charpentier, Ana-Maria Bozgan, Julio Badié, Charlotte Bourgoin, Rémy Contreras, I. Mazurier, Thierry Conrozier, Souheil Zayet
Topics & Concepts
TocilizumabARDSInternal medicineGastroenterologyFibrinogenFerritinMedicineD-dimerPlateletCoronavirus disease 2019 (COVID-19)ImmunologyDiseaseLungInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Vitamin C and Antioxidants Research